Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 7 de 7
Filtrer
1.
Sci Adv ; 8(12): eabm0220, 2022 03 25.
Article de Anglais | MEDLINE | ID: mdl-35333580

RÉSUMÉ

Conventional approaches to isolate and characterize nanobodies are laborious. We combine phage display, multivariate enrichment, next-generation sequencing, and a streamlined screening strategy to identify numerous anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nanobodies. We characterize their potency and specificity using neutralization assays and hydrogen/deuterium exchange mass spectrometry (HDX-MS). The most potent nanobodies bind to the receptor binding motif of the receptor binding domain (RBD), and we identify two exceptionally potent members of this category (with monomeric half-maximal inhibitory concentrations around 13 and 16 ng/ml). Other nanobodies bind to a more conserved epitope on the side of the RBD and are able to potently neutralize the SARS-CoV-2 founder virus (42 ng/ml), the Beta variant (B.1.351/501Y.V2) (35 ng/ml), and also cross-neutralize the more distantly related SARS-CoV-1 (0.46 µg/ml). The approach presented here is well suited for the screening of phage libraries to identify functional nanobodies for various biomedical and biochemical applications.


Sujet(s)
COVID-19 , Camélidés du Nouveau Monde , Anticorps à domaine unique , Animaux , Anticorps monoclonaux/composition chimique , Anticorps antiviraux , Camélidés du Nouveau Monde/métabolisme , Humains , Glycoprotéines membranaires , Tests de neutralisation , SARS-CoV-2 , Glycoprotéine de spicule des coronavirus , Protéines de l'enveloppe virale/métabolisme
2.
Nat Commun ; 13(1): 155, 2022 01 10.
Article de Anglais | MEDLINE | ID: mdl-35013189

RÉSUMÉ

Antibodies binding to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike have therapeutic promise, but emerging variants show the potential for virus escape. This emphasizes the need for therapeutic molecules with distinct and novel neutralization mechanisms. Here we describe the isolation of a nanobody that interacts simultaneously with two RBDs from different spike trimers of SARS-CoV-2, rapidly inducing the formation of spike trimer-dimers leading to the loss of their ability to attach to the host cell receptor, ACE2. We show that this nanobody potently neutralizes SARS-CoV-2, including the beta and delta variants, and cross-neutralizes SARS-CoV. Furthermore, we demonstrate the therapeutic potential of the nanobody against SARS-CoV-2 and the beta variant in a human ACE2 transgenic mouse model. This naturally elicited bispecific monomeric nanobody establishes an uncommon strategy for potent inactivation of viral antigens and represents a promising antiviral against emerging SARS-CoV-2 variants.


Sujet(s)
Anticorps bispécifiques/immunologie , Anticorps neutralisants/immunologie , Anticorps antiviraux/immunologie , COVID-19/immunologie , SARS-CoV-2/immunologie , Anticorps à domaine unique/immunologie , Glycoprotéine de spicule des coronavirus/immunologie , Animaux , Anticorps bispécifiques/métabolisme , COVID-19/virologie , Chlorocebus aethiops , Cryomicroscopie électronique , Cellules HEK293 , Humains , Souris transgéniques , Tests de neutralisation/méthodes , Liaison aux protéines , Conformation des protéines , Multimérisation de protéines/immunologie , SARS-CoV-2/métabolisme , SARS-CoV-2/physiologie , Anticorps à domaine unique/métabolisme , Glycoprotéine de spicule des coronavirus/composition chimique , Glycoprotéine de spicule des coronavirus/métabolisme , Cellules Vero
3.
Am J Surg ; 223(1): 157-163, 2022 Jan.
Article de Anglais | MEDLINE | ID: mdl-34330521

RÉSUMÉ

BACKGROUND: We aimed to describe the gender-based disparities in burn injury patterns, care received, and mortality across national income levels. METHODS: In the WHO Global Burn Registry (GBR), we compared patient demographics, injury characteristics, care and outcomes by sex using Chi-square statistics. Logistic regression was used to identify the associations of patient sex with surgical treatment and in-hospital mortality. RESULTS: Among 6431 burn patients (38 % female; 62 % male), females less frequently received surgical treatment during index hospitalization (49 % vs 56 %, p < 0.001), and more frequently died in-hospital (26 % vs 16 %, p < 0.001) than males. Odds of in in-hospital death was 2.16 (95 % CI: 1.73-2.71) times higher among females compared to males in middle-income countries. CONCLUSIONS: Across national income levels, there appears to be important gender-based disparities among burn injury epidemiology, treatment received and outcomes that require redress. Multinational registries can be utilized to track and to evaluate initiatives to reduce gender disparities at national, regional and global levels.


Sujet(s)
Unités de soins intensifs de brûlés/statistiques et données numériques , Brûlures/épidémiologie , Santé mondiale/statistiques et données numériques , Disparités de l'état de santé , Disparités d'accès aux soins/statistiques et données numériques , Adolescent , Adulte , Brûlures/diagnostic , Brûlures/chirurgie , Enfant , Enfant d'âge préscolaire , Femelle , Charge mondiale de morbidité , Mortalité hospitalière , Humains , Score de gravité des lésions traumatiques , Durée du séjour/statistiques et données numériques , Modèles logistiques , Mâle , Adulte d'âge moyen , Enregistrements/statistiques et données numériques , Études rétrospectives , Facteurs sexuels , Organisation mondiale de la santé , Jeune adulte
4.
Cell Rep Med ; 2(11): 100450, 2021 11 16.
Article de Anglais | MEDLINE | ID: mdl-34723224

RÉSUMÉ

Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) with resistance to neutralizing antibodies are threatening to undermine vaccine efficacy. Vaccination and infection have led to widespread humoral immunity against the pandemic founder (Wu-Hu-1). Against this background, it is critical to assess the outcomes of subsequent immunization with variant antigens. It is not yet clear whether heterotypic boosts would be compromised by original antigenic sin, where pre-existing responses to a prior variant dampen responses to a new one, or whether the memory B cell repertoire would bridge the gap between Wu-Hu-1 and VOCs. We show, in macaques immunized with Wu-Hu-1 spike, that a single dose of adjuvanted beta variant receptor binding domain (RBD) protein broadens neutralizing antibody responses to heterologous VOCs. Passive transfer of plasma sampled after Wu-Hu-1 spike immunization only partially protects K18-hACE2 mice from lethal challenge with a beta variant isolate, whereas plasma sampled following heterotypic RBD boost protects completely against disease.


Sujet(s)
Anticorps neutralisants/sang , Anticorps antiviraux/sang , Vaccins contre la COVID-19 , SARS-CoV-2/immunologie , Glycoprotéine de spicule des coronavirus/immunologie , Animaux , COVID-19 , Femelle , Cellules HEK293 , Humains , Macaca mulatta/immunologie , Mâle , Souris , Modèles animaux , SARS-CoV-2/métabolisme
5.
Int J Radiat Biol ; 96(2): 245-256, 2020 02.
Article de Anglais | MEDLINE | ID: mdl-31633433

RÉSUMÉ

Purpose: Vascular damage and inflammation are limiting toxic effects of lung cancer radiotherapy, which lead to pneumonitis and pulmonary fibrosis. We have demonstrated that soy isoflavones (SIF) mitigate these toxic effects at late time points after radiation. However, the process by which SIF impacts the onset of radiation-induced inflammation remains to be elucidated. We have now investigated early events of radiation-induced inflammation and identified cellular and molecular signaling patterns by endothelial cells that could be modified by SIF to control vascular damage and the initiation of lung inflammation.Materials and methods: Histopathological, cellular and molecular studies were performed on mouse lungs from C57Bl/6 mice treated with 10 Gy of thoracic radiation (XRT) in conjunction with daily oral SIF treatment given prior and after radiation. Parallel studies were performed in-vitro using EA.hy926 endothelial cell line with SIF and radiation. Immunohistochemistry, western blots analysis, and flow cytometry were performed on lung tissue or EA.hy926 cells to analyze endothelial cells, their patterns of cell death or survival, and signaling molecules involved in inflammatory events.Results: Histopathological differences in inflammatory infiltrates and vascular injury in lungs, including vascular endothelial cells, were observed with SIF treatment at early time points post-XRT. XRT-induced expression of proinflammatory adhesion molecule ICAM-1 cells was reduced by SIF in-vitro and in-vivo in endothelial cells. Molecular changes in endothelial cells with SIF treatment in conjunction with XRT included increased DNA damage, reduced cell viability and cyclin B1, and inhibition of nuclear translocation of NF-κB. Analysis of cell death showed that SIF treatment promoted apoptotic endothelial cell death and decreased XRT-induced type III cell death. In-vitro molecular studies indicated that SIF + XRT increased apoptotic caspase-9 activation and production of IFNß while reducing the release of inflammatory HMGB-1 and IL-1α, the cleavage of pyroptotic gasdermin D, and the release of active IL-1ß, which are all events associated with type III cell death.Conclusions: SIF + XRT caused changes in patterns of endothelial cell death and survival, proinflammatory molecule release, and adhesion molecule expression at early time points post-XRT associated with early reduction of immune cell recruitment. These findings suggest that SIF could mediate its radioprotective effects in irradiated lungs by limiting excessive immune cell homing via vascular endothelium into damaged lung tissue and curtailing the overall inflammatory response to radiation.


Sujet(s)
Cellules endothéliales/effets des radiations , Inflammation/prévention et contrôle , Isoflavones/pharmacologie , Poumon radique/prévention et contrôle , Radioprotecteurs/pharmacologie , Animaux , Femelle , Cellules endothéliales de la veine ombilicale humaine , Humains , Poumon/effets des radiations , Souris , Souris de lignée C57BL , Fibrose pulmonaire/prévention et contrôle , Radioprotection/méthodes , Transduction du signal
6.
Elife ; 62017 12 28.
Article de Anglais | MEDLINE | ID: mdl-29283341

RÉSUMÉ

The vertebrate embryo undergoes a series of dramatic morphological changes as the body extends to form the complete anterior-posterior axis during the somite-forming stages. The molecular mechanisms regulating these complex processes are still largely unknown. We show that the Hippo pathway transcriptional coactivators Yap1 and Wwtr1 are specifically localized to the presumptive epidermis and notochord, and play a critical and unexpected role in posterior body extension by regulating Fibronectin assembly underneath the presumptive epidermis and surrounding the notochord. We further find that Yap1 and Wwtr1, also via Fibronectin, have an essential role in the epidermal morphogenesis necessary to form the initial dorsal and ventral fins, a process previously thought to involve bending of an epithelial sheet, but which we now show involves concerted active cell movement. Our results reveal how the Hippo pathway transcriptional program, localized to two specific tissues, acts to control essential morphological events in the vertebrate embryo.


Sujet(s)
Épiderme/embryologie , Régulation de l'expression des gènes au cours du développement , Protéines et peptides de signalisation intracellulaire/métabolisme , Morphogenèse , Chorde/embryologie , Transactivateurs/métabolisme , Protéines de poisson-zèbre/métabolisme , Danio zébré/embryologie , Animaux , Fibronectines/métabolisme , Transcriptional coactivator with PDZ-binding motif proteins , Protéines de signalisation YAP
7.
J Health Care Poor Underserved ; 26(3): 761-70, 2015 Aug.
Article de Anglais | MEDLINE | ID: mdl-26320910

RÉSUMÉ

BACKGROUND: Vision problems in homeless children can decrease educational achievement and quality of life. PURPOSE: To estimate the prevalence and specific diagnoses of vision problems in children in an urban homeless shelter. METHODS: A prospective series of 107 homeless children and teenagers who underwent screening with a vision questionnaire, eye chart screening (if mature enough) and if vision problem suspected, evaluation by a pediatric ophthalmologist. Glasses and other therapeutic interventions were provided if necessary. RESULTS: The prevalence of vision problems in this population was 25%. Common diagnoses included astigmatism, amblyopia, anisometropia, myopia, and hyperopia. Glasses were required and provided for 24 children (22%). CONCLUSIONS: Vision problems in homeless children are common and frequently correctable with ophthalmic intervention. Evaluation by pediatric ophthalmologist is crucial for accurate diagnoses and treatment. Our system of screening and evaluation is feasible, efficacious, and reproducible in other homeless care situations.


Sujet(s)
Jeunes sans-abri/statistiques et données numériques , Troubles de la vision/diagnostic , Troubles de la vision/épidémiologie , Adolescent , Enfant , Enfant d'âge préscolaire , Colorado/épidémiologie , Lunettes correctrices/statistiques et données numériques , Femelle , Logement , Humains , Nourrisson , Mâle , Prévalence , Études prospectives , Enquêtes et questionnaires , Population urbaine/statistiques et données numériques , Troubles de la vision/thérapie , Dépistage visuel/méthodes , Jeune adulte
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE